Literature DB >> 7942810

Epidermal growth factor and endothelin in cyst fluid from autosomal dominant polycystic kidney disease cases: possible evidence of heterogeneity in cystogenesis.

C Munemura1, J Uemasu, H Kawasaki.   

Abstract

We determined the concentrations of immunoreactive epidermal growth factor (EGF), endothelin (ET), and cyclic adenosine monophosphate (cAMP) in cyst fluid from 10 nondialyzed patients with autosomal dominant polycystic kidney disease (ADPKD). The concentrations of ET and cAMP in low-sodium cyst fluid (cyst sodium concentration < 100 mEq/L) were significantly increased compared with those in high-sodium cyst fluid (cyst sodium concentration > or = 100 mEq/L), but the concentration of EGF did not differ between the two. There was no relationship between cyst fluid volume and EGF, ET, cAMP values in ADPKD cases. Significant variations of cyst fluid concentrations of EGF, ET, and cAMP were observed among the patients. However, the differences of these variables between the right and left kidney of the individual subjects were unremarkable. Serum levels of creatinine and urea nitrogen showed significant negative correlations with EGF, but not with ET and cAMP. The present data demonstrate the differences in cytokine activity among cysts in ADPKD cases, suggesting the heterogeneity of cystogenesis along the tubular segments in this particular disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7942810     DOI: 10.1016/s0272-6386(12)80212-5

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  15 in total

Review 1.  Potential pharmacological interventions in polycystic kidney disease.

Authors:  Amirali Masoumi; Berenice Reed-Gitomer; Catherine Kelleher; Robert W Schrier
Journal:  Drugs       Date:  2007       Impact factor: 9.546

2.  A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.

Authors:  R Pey; J Bach; G Schieren; N Gretz; M Hafner
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Nov-Dec       Impact factor: 2.416

3.  Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.

Authors:  Raghad Nemo; Noel Murcia; Katherine Macrae Dell
Journal:  Pediatr Res       Date:  2005-03-17       Impact factor: 3.756

4.  The association of endothelin-1 levels with renal survival in polycystic kidney disease patients.

Authors:  Ismail Kocyigit; Eray Eroglu; Ahmet Safa Kaynar; Derya Kocer; Seval Kargi; Gokmen Zararsiz; Ruslan Bayramov; Hakan Imamoglu; Murat Hayri Sipahioglu; Bulent Tokgoz; Munis Dundar; Oktay Oymak
Journal:  J Nephrol       Date:  2018-07-18       Impact factor: 3.902

Review 5.  Heterotrimeric G protein signaling in polycystic kidney disease.

Authors:  Taketsugu Hama; Frank Park
Journal:  Physiol Genomics       Date:  2016-05-13       Impact factor: 3.107

6.  Beta4 integrin and laminin 5 are aberrantly expressed in polycystic kidney disease: role in increased cell adhesion and migration.

Authors:  Dominique Joly; Viviane Morel; Aurélie Hummel; Antonella Ruello; Patrick Nusbaum; Natacha Patey; Laure-Hélène Noël; Patricia Rousselle; Bertrand Knebelmann
Journal:  Am J Pathol       Date:  2003-11       Impact factor: 4.307

Review 7.  Cardiovascular abnormalities in autosomal-dominant polycystic kidney disease.

Authors:  Tevfik Ecder; Robert W Schrier
Journal:  Nat Rev Nephrol       Date:  2009-04       Impact factor: 28.314

8.  Urinary EGF Receptor Ligand Excretion in Patients with Autosomal Dominant Polycystic Kidney Disease and Response to Tolvaptan.

Authors:  Laura R Harskamp; Ron T Gansevoort; Wendy E Boertien; Wim van Oeveren; Gerwin E Engels; Harry van Goor; Esther Meijer
Journal:  Clin J Am Soc Nephrol       Date:  2015-07-31       Impact factor: 8.237

9.  CXCR2 agonists in ADPKD liver cyst fluids promote cell proliferation.

Authors:  Claudia R Amura; Kelley S Brodsky; Berenice Gitomer; Kim McFann; Gwendal Lazennec; Matthew T Nichols; Alkesh Jani; Robert W Schrier; R Brian Doctor
Journal:  Am J Physiol Cell Physiol       Date:  2008-01-16       Impact factor: 4.249

Review 10.  Modulation of polycystic kidney disease by G-protein coupled receptors and cyclic AMP signaling.

Authors:  Caroline R Sussman; Xiaofang Wang; Fouad T Chebib; Vicente E Torres
Journal:  Cell Signal       Date:  2020-04-23       Impact factor: 4.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.